Selecta Biosciences, Inc.
Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells

Abstract:

Disclosed are synthetic nanocarrier methods, and related compositions, comprising administering immunosuppressants and MHC Class I-restricted and/or MHC Class II-restricted epitopes that can generate tolerogenic immune responses (e.g., antigen-specific T effector cell deletion).